{"schemaVersion":1,"profileUrl":"https://nowen.ai/agents/sanofi-com","markdownUrl":"https://nowen.ai/agents/sanofi-com.md","jsonUrl":"https://nowen.ai/agents/sanofi-com.json","name":"Sanofi","website":"https://sanofi.com","location":"Paris, France","address":{"city":"Paris","country":"France"},"industry":"Biopharma","deliveryModel":"services","status":{"trust":"unclaimed","text":"Unclaimed: compiled by Nowen from public sources, not reviewed by the company"},"updatedAt":"2026-11-05T19:21:51.237Z","summary":"Sanofi is a research-driven biopharmaceutical company developing medicines and vaccines to improve people’s lives.","description":"Sanofi is an R&D-driven, AI-powered biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for people worldwide. It applies its scientific expertise and technology platforms to address complex health needs, improve patient access to care, and support healthier, more resilient communities.","mission":"We chase the miracles of science to improve people’s lives.","directory":{"industryName":"Biopharma","agentCount":2,"indexable":false,"hubUrl":"https://nowen.ai/industry/biopharma"},"aiReaderFamilies":["OpenAI","Perplexity","Meta"],"products":[{"name":"Medicines","anchor":"product-medicines","type":"Service","url":"https://www.sanofi.com/en/our-company","summary":"Treats and helps prevent complex diseases through medicines spanning multiple therapeutic areas, with efforts to improve access, quality, and safety.","description":"Sanofi discovers, develops, and delivers medicines for patients worldwide. Its medicines address complex diseases across therapeutic areas including immunology, respiratory diseases, gastroenterology, dermatology, oncology, neurology, and rare diseases. Sanofi also works to expand access to quality medicines and applies environmental considerations throughout product life cycles.","pricing":{},"features":[{"name":"Broad therapeutic coverage","value":"Address Diverse Health Needs","valueDescription":"Sanofi's medicines target diseases across multiple therapeutic areas, including complex and rare diseases."},{"name":"Access and affordability programs","value":"Expand Access To Quality Medicines","valueDescription":"Access programs aim to make medicines available and affordable for underserved populations, including communities in countries with high unmet medical needs and those affected by crises."},{"name":"Immune-system research","value":"Advance Immune-System-Based Treatments","valueDescription":"Research into the immune system informs the development of medicines intended to improve treatment and prevention of disease."},{"name":"Essential medicine portfolio","value":"Provide Essential Treatment Options","valueDescription":"The Impact portfolio includes medicines for people living with diabetes, cardiovascular disease, cancer, and other diseases, with availability across 40 vulnerable countries."},{"name":"Medicine quality and safety monitoring","value":"Monitor Medicine Quality And Safety","valueDescription":"Ongoing quality management and pharmacovigilance activities support product quality and safety monitoring throughout the product life cycle."},{"name":"Medicine eco-design","value":"Reduce Product Lifecycle Footprints","valueDescription":"Eco-design applies environmental considerations across the medicine life cycle, including materials, manufacturing, distribution, and end-of-life treatment."},{"name":"Early global access planning","value":"Plan Broader Patient Access","valueDescription":"Considering access early in clinical development helps Sanofi assess how broader access to future medicines may be accelerated."}]},{"name":"Vaccines","anchor":"product-vaccines","type":"Service","url":"https://www.sanofi.com/en/our-science/therapeutic-areas/vaccines-research-development","summary":"Supports disease prevention and population health through vaccines, access initiatives, and immunization programs.","description":"Sanofi discovers, develops, and delivers vaccines for people around the world. Its vaccine work is supported by research and manufacturing platforms, including mRNA, and spans disease prevention, access initiatives, and environmental eco-design. Sanofi also monitors product quality and safety throughout the product life cycle.","pricing":{},"features":[{"name":"Disease prevention","value":"Help Prevent Disease","valueDescription":"Vaccination supports disease prevention and can improve outcomes across populations."},{"name":"Equitable vaccine access","value":"Expand Equitable Vaccine Access","valueDescription":"Access initiatives address the availability and affordability of vaccines for underserved communities. Sanofi reports supplying billions of polio vaccine doses worldwide through its longstanding contribution to polio eradication efforts."},{"name":"Vaccine quality and safety monitoring","value":"Monitor Vaccine Quality And Safety","valueDescription":"Ongoing quality management and product safety monitoring help Sanofi oversee vaccines throughout their life cycle and collaborate with authorities worldwide."},{"name":"mRNA technology platform","value":"Leverage mRNA Technology","valueDescription":"The mRNA platform is part of the technology and manufacturing capabilities Sanofi draws on in its work to develop vaccines."},{"name":"Environmental eco-design","value":"Reduce Product Footprint","valueDescription":"Eco-design considers environmental impact throughout a vaccine's value chain, including manufacturing, distribution, and end-of-life treatment."},{"name":"Reduced care-related emissions through immunization","value":"Reduce Emissions From Care","valueDescription":"By helping prevent disease, immunization can reduce the need for resource-intensive care and the emissions associated with related health services and travel."}]},{"name":"Global Health Unit","anchor":"product-global-health-unit","type":"Service","url":"https://www.sanofi.com/en/our-company/sustainability/global-health-unit","summary":"Expands access to quality medicines and care while strengthening local health systems in underserved communities.","description":"Sanofi's not-for-profit unit works to improve access to quality medicines and care for people in 40 countries with high unmet medical needs, with a focus on non-communicable diseases. Through cross-sector partnerships, it supports patients throughout their healthcare journey, strengthens local health systems, and funds local support programs and innovative entrepreneurs to help build sustainable solutions. Its Impact brand makes a portfolio of quality medicines available and affordable in vulnerable countries, including medicines for diabetes, cardiovascular disease, cancer, and other conditions.","pricing":{},"features":[{"name":"Access to quality and essential medicines","value":"Expand Access To Essential Medicines","valueDescription":"Helps people in underserved and vulnerable countries access quality, affordable medicines for conditions including diabetes, cardiovascular disease, and cancer."},{"name":"Support across the healthcare journey","value":"Support Patients Across Their Care Journey","valueDescription":"Connects awareness, screening, treatment, and continued management as part of efforts to address gaps in non-communicable disease care."},{"name":"Local health system strengthening","value":"Strengthen Local Health Systems","valueDescription":"Builds local capacity for healthcare by supporting training, community health initiatives, and the development of sustainable systems for quality care."},{"name":"Cross-sector healthcare partnerships","value":"Build Partnerships For Local Health Impact","valueDescription":"Brings together partners across sectors and geographies to develop healthcare initiatives that respond to underserved communities' needs."},{"name":"Inclusive healthcare access models","value":"Design Inclusive Access Models","valueDescription":"Adapts healthcare access approaches to local populations and systems, supporting more inclusive care and progress toward universal health coverage."},{"name":"Impact investment and entrepreneur support","value":"Fund Healthcare Innovators","valueDescription":"Provides financing and technical assistance to small businesses developing healthcare solutions for underserved regions."}]},{"name":"AccesS Diabetes","anchor":"product-access-diabetes","type":"Service","url":"https://www.sanofi.com/en/our-company/sustainability/sustainable-and-equitable-access-to-healthcare","summary":"Improves access to diabetes care for underserved communities through awareness, screening, patient support, practitioner training, and adapted-price insulin.","description":"AccesS Diabetes is a Sanofi initiative to support sustainable and equitable access to diabetes care for underserved populations. Co-created with global and local actors, it works with governments in low- and middle-income countries, including Ghana, Nigeria, and South Africa. The initiative addresses key parts of the patient journey through awareness, screening capacity, patient support initiatives, healthcare practitioner training, and the provision of analogue insulins at an adapted price.","pricing":{},"features":[{"name":"Adaptively priced analogue insulin access","value":"Provide Adaptively Priced Analogue Insulin","valueDescription":"The initiative provides analogue insulins at an adapted price as part of its efforts to support sustainable and equitable access to diabetes care."},{"name":"Screening capacity","value":"Expand Screening Capacity","valueDescription":"The initiative supports screening capacity to help address a crucial aspect of the diabetes patient journey."},{"name":"Patient support initiatives","value":"Support People With Diabetes","valueDescription":"Patient support initiatives form part of the initiative's efforts to improve access to diabetes care for underserved populations."},{"name":"Healthcare practitioner training","value":"Train Healthcare Practitioners","valueDescription":"Training healthcare practitioners supports the care pathway addressed by AccesS Diabetes."},{"name":"Government and stakeholder collaboration","value":"Collaborate With Governments And Local Actors","valueDescription":"The initiative works with governments and is co-created with global and local actors to support diabetes care in low- and middle-income countries, including Ghana, Nigeria, and South Africa."},{"name":"Diabetes awareness","value":"Build Diabetes Awareness","valueDescription":"Awareness efforts address an important part of the diabetes patient journey and help communities learn about the condition."}]},{"name":"Kids and Diabetes in Schools (KiDS)","anchor":"product-kids-and-diabetes-in-schools-kids","type":"Service","url":"https://www.sanofi.com/en/our-company/sustainability/sustainable-and-equitable-access-to-healthcare","summary":"Helps schools support children with diabetes, reduce stigma, and promote healthy lifestyles that address preventable type 2 diabetes risk factors.","description":"Since 2013, Sanofi has partnered with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes to bring diabetes education to schools. The program aims to combat diabetes-related stigma and promote healthy lifestyles to address preventable risk factors for type 2 diabetes. Sanofi reports that around 20,000 teachers and school staff have been trained through KiDS on type 1 diabetes and how to support children managing it.","pricing":{},"features":[{"name":"School diabetes education","value":"Bring Diabetes Education Into Schools","valueDescription":"Provides a school-based setting for diabetes education, supported by partnerships with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes."},{"name":"Teacher and school staff training","value":"Train Staff To Support Children","valueDescription":"Equips teachers and school staff with training on type 1 diabetes and ways to support children managing it at school."},{"name":"Diabetes stigma reduction","value":"Help Reduce Diabetes-Related Stigma","valueDescription":"Addresses diabetes-related stigma as a stated aim of the program, using school-based diabetes education."},{"name":"Healthy lifestyle promotion","value":"Promote Healthy Lifestyle Choices","valueDescription":"Encourages healthy lifestyles as part of the program's effort to address preventable risk factors for type 2 diabetes."}]}],"audiences":[],"segments":[],"faq":[],"comparisons":[],"sources":[{"url":"https://sanofi.com","text":"Sanofi"},{"url":"https://www.sanofi.com/en/our-company","text":"Medicines"},{"url":"https://www.sanofi.com/en/our-science/therapeutic-areas/vaccines-research-development","text":"Vaccines"},{"url":"https://www.sanofi.com/en/our-company/sustainability/global-health-unit","text":"Global Health Unit"},{"url":"https://www.sanofi.com/en/our-company/sustainability/sustainable-and-equitable-access-to-healthcare","text":"AccesS Diabetes"}]}